EDWARDS PERICARDIAL AORTIC BIOPROSTHESIS (MODEL 11000A) and EDWARDS INSPIRIS RESILIA AORTIC VALVE (MODEL 11500)
Edwards Lifesciences, LLC · Decision date Jun 29, 2017
What did the FDA approve?
The FDA database entry records an approval decision dated June 29, 2017, for PMA P150048 submitted by Edwards Lifesciences, LLC. The decision field is APPR, and the product code is LWR under the cardiovascular specialty.
The statement names two devices: the Edwards Pericardial Aortic Bioprosthesis, Model 11000A, and the Edwards INSPIRIS RESILIA Aortic Valve, Model 11500A. Both are described as indicated for replacement of native or prosthetic aortic heart valves. The entry does not include supplement type, supplement reason, or clinical performance data.
FDA approval order statement
Approval of the Edwards Pericardial Aortic Bioprosthesis and Edwards INSPIRIS RESILIA Aortic Valve. The Edwards Pericardial Aortic Bioprosthesis, Model 11000A, is indicated for the replacement of native or prosthetic aortic heart valves. The Edwards INSPIRIS RESILIA Aortic Valve, Model 11500A, is indicated for the replacement of native or prosthetic aortic heart valves.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Cardiovascular
- Decision date
- Jun 29, 2017
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P150048
- Regulatory pathway
- Premarket approval application
- Applicant
- Edwards Lifesciences, LLC
- Product code
- LWR
- Decision code
- APPR
- Decision date
- Jun 29, 2017
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: heart-valve, non-allograft tissue.
- Applicant
- Edwards Lifesciences, LLC
- Product code
- LWR
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P150048 received
Application receipt date recorded by FDA.
P150048 · FDA decision
APPR
P150048/S100 · Related supplement
INSPIRIS RESILIA Aortic Valve; MITRIS RESILIA Mitral Valve
P150048/S104 · Related supplement
INSPIRIS RESILIA Aortic Valve (11500A), KONECT RESILIA Aortic Valve Conduit (AVC) (11060A), MITRIS RESILIA Mitral Valv
Timeline entries are records held by MedtechLedger for P150048. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P150048
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Edwards Lifesciences, LLC | PMA supplement | Oct 22, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Oct 28, 2026 | FDA |
Explore the linked device profile
Other records with product code LWR
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
EDWARDS INTUITY Elite Valve System (8300AB)P150036/S081 | Edwards Lifesciences, LLC | PMA supplement | Oct 28, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | Sep 18, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA approval | Aug 12, 2016 | FDA | |
| ABBOTT MEDICAL | PMA approval | Aug 5, 2005 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Edwards Lifesciences, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- One Edwards Way, Irvine, CA, 92614
Sources and methodology
- Original FDA record: P150048
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records